Topic:

Manufacturing

Latest Headlines

Latest Headlines

South Korea's Green Cross teams with Russia's Nanolek on biologics manufacturing

South Korea's Green Cross said it has signed an agreement with Nanolek, a Russia biopharmaceutical company, to produce its biologics in a three-month-old facility said to be state-of-the-art.

Pleasantries aside, U.S. FDA keeps sharp eye on India pharma manufacturing

The exchange of niceties and promises of softness in recent meetings with India counterparts notwithstanding, the U.S. FDA continues to take harsh action against India drug-production plants. The latest is a ban on imports from two more Ipca Laboratories plants.

Human albumin shortage in India may prompt emergency measures

India regulators are mulling whether to invoke emergency procedures and order drugmakers to produce and distribute more human albumin, which has been in short supply for nearly a year.

India's Gujarat set to train food and drug inspectors in first state effort

India's Gujarat state government has signed a memorandum of understanding with Underwriters Laboratories to train 60 food-and-drug inspectors to work under the Food and Drug Control Authority.

India's Wockhardt faces mass of lawsuits in U.S. over generic Reglan

Wockhardt's U.S. affiliate must face a mass of suits in a state court over its generic version of the acid reflux drug Reglan (metoclopramide), developed by Wyeth before the firm was bought by Pfizer.

India threatens restrictions on China pharma imports

India's government has threatened to place restrictions on imports of nonessential items, including pharmaceuticals, from China if it does not ease some of its "protectionist tendencies" toward India products.

Lee Kuan Yew remembered for focused effort to build Singapore into a pharma, biotech center

Lee Kuan Yew, Singapore's first prime minister, who developed the small city-state into a vibrant manufacturing center for petrochemicals, shipping, electronics and a financial hub also leaves a legacy for the drug and biotech industry in Asia that will play out over decades.

India plans pharma manufacturing clusters to ease costs

India's health ministry said the government plans to spend $27.3 million to establish ten clusters around the country for drug makers to share common production facilities and reduce their costs by 25%.

Indonesia drug industry investment lags despite universal insurance program

Indonesia's new and ambitious healthcare program has done little to infuse new money into the country's pharmaceutical industry, partly because of a long-term weakness in the nation's currency, the rupiah, according a review of company reports.

U.S.-based lawsuits pile up for Japan's Olympus in superbug case

Olympus Medical Systems has received its fifth suit filed by a patient claiming to have been infected with the hospital "superbug" as a result of inadequate sterilization of its duodenoscope.